Financial giants have made a conspicuous bullish move on Corcept Therapeutics. Our analysis of options history for Corcept Therapeutics CORT revealed 38 unusual trades.
Delving into the details, we found 42% of traders were bullish, while 34% showed bearish tendencies. Out of all the trades we spotted, 4 were puts, with a value of $282,776, and 34 were calls, valued at $3,592,834.
Expected Price Movements
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $20.0 and $110.0 for Corcept Therapeutics, spanning the last three months.
Analyzing Volume & Open Interest
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Corcept Therapeutics's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Corcept Therapeutics's significant trades, within a strike price range of $20.0 to $110.0, over the past month.
Corcept Therapeutics Call and Put Volume: 30-Day Overview
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CALL | TRADE | BEARISH | 08/15/25 | $22.9 | $20.2 | $20.6 | $95.00 | $412.0K | 0 | 201 |
| CORT | CALL | TRADE | NEUTRAL | 01/16/26 | $34.3 | $31.3 | $32.7 | $90.00 | $317.1K | 726 | 200 |
| CORT | CALL | TRADE | BEARISH | 01/16/26 | $32.5 | $31.5 | $31.5 | $90.00 | $315.0K | 726 | 300 |
| CORT | CALL | TRADE | BEARISH | 01/16/26 | $31.7 | $28.3 | $28.3 | $90.00 | $283.0K | 726 | 100 |
| CORT | CALL | SWEEP | BEARISH | 01/16/26 | $24.3 | $22.0 | $22.32 | $100.00 | $220.6K | 91 | 40 |
About Corcept Therapeutics
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.
After a thorough review of the options trading surrounding Corcept Therapeutics, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
Present Market Standing of Corcept Therapeutics
- With a trading volume of 8,640,882, the price of CORT is up by 85.93%, reaching $101.57.
- Current RSI values indicate that the stock is may be overbought.
- Next earnings report is scheduled for 30 days from now.
What The Experts Say On Corcept Therapeutics
1 market experts have recently issued ratings for this stock, with a consensus target price of $150.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access. * Maintaining their stance, an analyst from HC Wainwright & Co. continues to hold a Buy rating for Corcept Therapeutics, targeting a price of $150.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Corcept Therapeutics, Benzinga Pro gives you real-time options trades alerts.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
